ALLOY THERAPEUTICS
Alloy Therapeutics makes medicine by democratizing access to foundational drug discovery platforms and services. Alloy-Gx, its first platform, is a royalty-free suite of immunocompetent transgenic mice enabling best-in-class in vivo human antibody discovery. Founded in 2017, Alloy Therapeutics is headquartered in Waltham, Massachusetts.
ALLOY THERAPEUTICS
Industry:
Biopharma Biotechnology Life Science Therapeutics
Founded:
2017-01-01
Status:
Active
Total Funding:
128.25 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics LetsEncrypt Amazon
Similar Organizations
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-09 | deepCDR Biologics | deepCDR Biologics acquired by Alloy Therapeutics | N/A |
Investors List
8VC
8VC investment in Series D - Alloy Therapeutics
Presight Capital
Presight Capital investment in Series D - Alloy Therapeutics
Founders Fund
Founders Fund investment in Series D - Alloy Therapeutics
Thiel Capital
Thiel Capital investment in Series D - Alloy Therapeutics
Mubadala Capital Ventures
Mubadala Capital Ventures investment in Series D - Alloy Therapeutics
8VC
8VC investment in Series C - Alloy Therapeutics
Bossanova Investimentos
Bossanova Investimentos investment in Series C - Alloy Therapeutics
Gaingels
Gaingels investment in Series C - Alloy Therapeutics
Luma Bio-IT
Luma Bio-IT investment in Series C - Alloy Therapeutics
Mubadala Capital Ventures
Mubadala Capital Ventures investment in Series C - Alloy Therapeutics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-10-04 | Wheeler Bio | Alloy Therapeutics investment in Series A - Wheeler Bio | 31 M USD |
| 2022-06-02 | Vernal Biosciences | Alloy Therapeutics investment in Series A - Vernal Biosciences | 21 M USD |
| 2022-04-06 | Tegmine Therapeutics | Alloy Therapeutics investment in Corporate Round - Tegmine Therapeutics | N/A |
| 2022-03-08 | Mytide Therapeutics | Alloy Therapeutics investment in Series A - Mytide Therapeutics | 7 M USD |
| 2022-01-04 | Wheeler Bio | Alloy Therapeutics investment in Seed Round - Wheeler Bio | 14 M USD |
| 2021-07-21 | Wheeler Bio | Alloy Therapeutics investment in Seed Round - Wheeler Bio | N/A |
| 2021-07-12 | Vernal Biosciences | Alloy Therapeutics investment in Seed Round - Vernal Biosciences | N/A |
Key Employee Changes
More informations about "Alloy Therapeutics"
Alloy Therapeutics Team
We are a passionate team of scientists and engineers working from 5 research sites in 3 different countries. As our name implies, we do all our work in collaboration with our hundreds of …See details»
Alloy Therapeutics - Crunchbase Investor Profile
Alloy Therapeutics is a biotech company that makes medicine by democratizing access to foundational drug discovery platforms and services. View contacts for Alloy Therapeutics to access new leads and connect with decision-makers.See details»
Alloy's Drug Discovery Technologies & Services …
Jan 9, 2023 Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together.See details»
Alloy Therapeutics (Switzerland) AG – Swiss Biotech
Alloy Therapeutics is a biotechnology ecosystem company democratizing access to tools, technologies, and services for discovering and developing therapeutic biologics across six modalities, including antibodies, TCRs, genetic medicines, …See details»
Alloy Therapeutics to empower drug discovery of Lundbeck’s …
May 2, 2023 Alloy Therapeutics, a biotechnology ecosystem company, announced it is collaborating with Lundbeck, a global pharmaceutical company specializing in brain diseases, …See details»
Alloy Therapeutics and Wheeler Bio Announce …
Nov 8, 2023 Alloy Therapeutics, Inc., is a biotechnology ecosystem company empowering the global scientific community to make better medicines together.See details»
Foley Hoag Represents Alloy Therapeutics in Strategic …
5 days ago Foley Hoag LLP represented biotechnology ecosystem company Alloy Therapeutics Inc. ("Alloy") in a strategic collaboration and license agreement with Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) …See details»
Alloy Therapeutics - Funding, Financials, Valuation & Investors
Alloy Therapeutics is a biotech company that makes medicine by democratizing access to foundational drug discovery platforms and services.See details»
Alloy Therapeutics - workinbiotech.com
Alloy Therapeutics describes itself as a biotechnology ecosystem company that enables pre-competitive drug discovery at all levels. Alloy currently offers licensing in antibody and TCR …See details»
Media - Alloy Therapeutics
Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together.See details»
Alloy Therapeutics - Leadership Team - The Org
The Leadership Team at Alloy Therapeutics is responsible for strategic direction and oversight of the company’s initiatives in biotechnology, focusing on empowering collaboration within the …See details»
Alloy Therapeutics - VentureRadar
"Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together.See details»
Alloy Therapeutics - Overview, News & Similar companies
BOSTON-- (BUSINESS WIRE)--Alloy Therapeutics, a biotechnology ecosystem company dedicated to democratizing access to biologics drug discovery platforms and services, …See details»
Alloy Therapeutics and Wheeler Bio Announce Preferred Service …
Alloy Therapeutics, Inc., is a biotechnology ecosystem company empowering the global scientific community to make better medicines together.See details»
Woodbridge biotech gets FDA ‘orphan’ status for anti-tumor drug
Federal regulators have deemed a Woodbridge biotechnology company’s tumor-fighting therapy an ‘orphan’ drug, making it eligible for financial incentives. AlloMek Therapeutics earned the …See details»
Contact - Alloy Therapeutics
Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. As a reflection of Alloy’s relentless commitment …See details»
AlloMek Therapeutics Company Profile | Management and
AlloMek Therapeutics Profile and History. AlloMek, founded in 2011, is a privately held orphan disease-focused company, developing therapeutics for catastrophic cardiomyopathy (based …See details»
Boston & New England Biotech Companies - Pharmaceuticals, …
Alloy Therapeutics : MA - Waltham: Antibody Discovery Platform: Alltrna : MA - Cambridge: tRNA therapies: ... Novel therapeutics for the treatment of neuropsychiatric diseases: Eutropics …See details»
AlloMEK Therapeutics Company Profile 2024: Valuation, Investors ...
AlloMEK Therapeutics General Information Description. Developer of targeted therapeutics intended to treat rare and debilitating diseases. The company's therapeutics include kinase …See details»
Alloy Therapeutics and Wheeler Bio Announce Preferred Service …
Boston, Mass. & Oklahoma City, Okla. — Alloy Therapeutics, Inc., a biotechnology ecosystem company and Wheeler Bio Inc, an agile contract development and manufacturing organization …See details»